Effects of postmenopausal hormone therapy on rheumatoid arthritis: The women's health initiative randomized controlled trials
Authors:
- Brian WalittBWBrian Walitt
- Women's Health Initiative InvestigatorsWIWomen's Health Initiative Investigators
Open Access
- 29 February 2008
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 59 (3) , 302-310
Abstract
Objective: To study the effects of postmenopausal hormone therapy (PHT) on the incidence and severity of rheumatoid arthritis (RA).Methods: The Women's Health Initiative randomized controlled trials evaluated the effects of unopposed estrogen (E‐alone) and estrogen plus progestin (E+P) compared with placebo on a diverse set of health outcomes over 7.1 and 5.6 years, respectively. RA cases were identified using historical and medication data. The hazard of developing RA was estimated using Cox proportional hazards regression models. Disease symptom severity was estimated using the Short Form 36 (SF‐36) and self‐reported joint pain scores at baseline and after 1 year. Mean changes in severity were compared using linear regression models.Results: Of the 27,347 participants, 63 prevalent cases and 105 incident cases of RA were identified. A nonsignificant reduction in the risk of developing RA (hazard ratio 0.74; 95% confidence interval [95% CI] 0.51, 1.10) was noted with PHT use. PHT use led to improved SF‐36 scores in unadjusted analyses (percent change 12.5%; 95% CI −24.45, −0.57) but not after adjustment for relevant covariates (P = 0.33). Nonsignificant improvements in joint pain scores were seen with PHT use (odds ratio [OR] 4.10; 95% CI 0.83, 20.20). PHT did not improve swelling (OR 1.27; 95% CI 0.08, 19.63) or prevent new joint pains (OR 0.72; 95% CI 0.11, 4.68) in RA participants.Conclusion: There were no statistically significant differences in the risk of developing RA or the severity of RA between the PHT and placebo groups.Keywords
This publication has 39 references indexed in Scilit:
- 17β‐estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte‐derived macrophagesArthritis & Rheumatism, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- The Prevalence and Severity of Rheumatoid Arthritis in OsloScandinavian Journal of Rheumatology, 1997
- A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis.Annals of the Rheumatic Diseases, 1994
- Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study.Annals of the Rheumatic Diseases, 1994
- Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Analysis of thymocyte subpopulations following treatment with sex hormonesClinical Immunology and Immunopathology, 1983
- Cyclic variations in white cell subpopulations in the human menstrual cycle: Correlations with progesterone and estradiolClinical Immunology and Immunopathology, 1979